Millennium Management’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $359K | Buy |
38,149
+7,349
| +24% | +$69.2K | ﹤0.01% | 3503 |
|
2025
Q1 | $167K | Sell |
30,800
-415,399
| -93% | -$2.25M | ﹤0.01% | 3680 |
|
2024
Q4 | $3.32M | Buy |
+446,199
| New | +$3.32M | ﹤0.01% | 2240 |
|
2024
Q3 | – | Sell |
-580,716
| Closed | -$5.05M | – | 4192 |
|
2024
Q2 | $5.05M | Sell |
580,716
-1,465,722
| -72% | -$12.8M | ﹤0.01% | 1923 |
|
2024
Q1 | $42.3M | Buy |
2,046,438
+917,800
| +81% | +$19M | 0.02% | 626 |
|
2023
Q4 | $26.1M | Buy |
1,128,638
+548,009
| +94% | +$12.7M | 0.01% | 889 |
|
2023
Q3 | $4.64M | Buy |
580,629
+241,682
| +71% | +$1.93M | ﹤0.01% | 1931 |
|
2023
Q2 | $2.95M | Sell |
338,947
-272,231
| -45% | -$2.37M | ﹤0.01% | 2287 |
|
2023
Q1 | $1.8M | Sell |
611,178
-64,255
| -10% | -$189K | ﹤0.01% | 2619 |
|
2022
Q4 | $2.36M | Buy |
675,433
+265,147
| +65% | +$928K | ﹤0.01% | 2605 |
|
2022
Q3 | $3.25M | Buy |
410,286
+67,063
| +20% | +$530K | ﹤0.01% | 2520 |
|
2022
Q2 | $2.7M | Buy |
343,223
+187,958
| +121% | +$1.48M | ﹤0.01% | 2642 |
|
2022
Q1 | $1.89M | Buy |
155,265
+32,062
| +26% | +$389K | ﹤0.01% | 3108 |
|
2021
Q4 | $1.51M | Buy |
123,203
+86,000
| +231% | +$1.05M | ﹤0.01% | 3170 |
|
2021
Q3 | $388K | Sell |
37,203
-465,468
| -93% | -$4.85M | ﹤0.01% | 4350 |
|
2021
Q2 | $4.52M | Buy |
502,671
+210,615
| +72% | +$1.89M | ﹤0.01% | 2247 |
|
2021
Q1 | $2.97M | Buy |
292,056
+267,272
| +1,078% | +$2.72M | ﹤0.01% | 2528 |
|
2020
Q4 | $163K | Buy |
+24,784
| New | +$163K | ﹤0.01% | 3811 |
|
2020
Q3 | – | Sell |
-5,598
| Closed | -$42K | – | 3689 |
|
2020
Q2 | $42K | Sell |
5,598
-44,542
| -89% | -$334K | ﹤0.01% | 3326 |
|
2020
Q1 | $511K | Buy |
+50,140
| New | +$511K | ﹤0.01% | 2296 |
|
2019
Q2 | – | Sell |
-93,967
| Closed | -$1.68M | – | 3555 |
|
2019
Q1 | $1.68M | Buy |
+93,967
| New | +$1.68M | ﹤0.01% | 2128 |
|
2018
Q4 | – | Sell |
-7,788
| Closed | -$278K | – | 3434 |
|
2018
Q3 | $278K | Buy |
7,788
+2,029
| +35% | +$72.4K | ﹤0.01% | 3129 |
|
2018
Q2 | $120K | Buy |
+5,759
| New | +$120K | ﹤0.01% | 3255 |
|
2017
Q4 | – | Sell |
-4,363
| Closed | -$52K | – | 3594 |
|
2017
Q3 | $52K | Sell |
4,363
-17,888
| -80% | -$213K | ﹤0.01% | 3147 |
|
2017
Q2 | $380K | Buy |
+22,251
| New | +$380K | ﹤0.01% | 2699 |
|
2016
Q2 | – | Sell |
-3,668
| Closed | -$98K | – | 3014 |
|
2016
Q1 | $98K | Sell |
3,668
-8,545
| -70% | -$228K | ﹤0.01% | 2845 |
|
2015
Q4 | $589K | Buy |
12,213
+10,661
| +687% | +$514K | ﹤0.01% | 2364 |
|
2015
Q3 | $57K | Buy |
+1,552
| New | +$57K | ﹤0.01% | 3124 |
|
2014
Q2 | – | Sell |
-1,866
| Closed | -$76K | – | 2869 |
|
2014
Q1 | $76K | Buy |
+1,866
| New | +$76K | ﹤0.01% | 2569 |
|
2013
Q4 | – | Sell |
-28,000
| Closed | -$1.15M | – | 2687 |
|
2013
Q3 | $1.15M | Buy |
+28,000
| New | +$1.15M | ﹤0.01% | 1600 |
|